Home FUNDING

FUNDING

Dextera Surgical Announces $8 Million Underwritten Public Offering

Dextera Surgical Inc. (NASDAQ:DXTR), a company developing and commercializing the MicroCutter 5/80™ stapler based on its proprietary ‘‘staple-on-a-strip’’ technology intended for use by thoracic, pediatric, colorectal and general surgeons, today announced that it has priced a firm...

Axonics® Announces $14.5 Million First Close of Series C Financing

“These world-class investors have provided Axonics with phenomenal support throughout the development phase of our project, including attainment of key milestones such as European and Canadian regulatory approval and completion of our 50-patient European clinical study,” said...

Avedro Announces $42 Million in Funding to Support Commercial Expansion and Pipeline Development

April 27, 2017 Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that it secured a combined $42 million in equity and debt financing. Avedro, Inc. notes the equity financing was...

BIOLASE to Raise $10.5 Million from Institutional and Individual Investors in a Private Placement

BIOLASE reports under the terms of the private placement, BIOLASE has agreed to sell an aggregate of 80,644 shares of a newly created series of its convertible preferred stock at a per share price of $124.00.

Neural Analytics Raises $10 Million in New Funding Round

The investment brings Neural Analytics’ total funding to $27 million. Ted Koutouzis, M.D. of Reimagined Ventures will join Neural Analytics’ Board of Directors.

Vascular Dynamics Completes $10.4 Million Financing

Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces it has completed a $10.4 million financing. The private placement included all major current investors in Vascular Dynamics. ...

Cardiva Medical Raises $30 Million: Financing to Be Used for Commercial Expansion of the VASCADE Vascular Closure System

The financing will be used to continue the rapid commercial expansion of the VASCADE® Vascular Closure System and to fund Cardiva’s proprietary, next-generation closure technologies that are in development.